Healthcare Distribution Alliance

National trade association comprised of primary healthcare distributors

Based in VA

🤖

AI Overview

With $1.7M in lobbying spend across 29 quarterly filings, Healthcare Distribution Alliance is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2019 to 2025.

$1.7M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2019	$220K
2020	$240K
2021	$240K
2022	$240K
2023	$240K
2024	$240K
2025	$240K

Issues Lobbied

Health Issues Pharmacy Budget/Appropriations Medicare/Medicaid

Lobbying Firms

Government Counsel, LLC

Lobbyists

Henry Menn

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy, Budget/Appropriations, Medicare/Medicaid

•Issues relating to affordable pharmaceutical pricing

•General issues related to opioid abuse (implementation of Public Law 115-271) and ARCOS data.

•Issues related to ARCOS data and suspicious order record requirements and reporting;importation of prescription drugs (HR 447, HR 478, HR 1478, S 61, S 97, S 658, S 844); implementation of Public Law

•Issues related to ARCOS data and suspicious order record requirements and reporting;
•H.R.3878-Block, Report, And Suspend Suspicious Shipments Act of 2019; importation of prescription drugs (HR 447, HR

•Issues related to ARCOS data and suspicious order record requirements and reporting: S.3070-Preventing Pill Mills Through Data Sharing Act; S. 2686 & H.R. 4814-Suspicious Order Identification Act of 2